Pfizer- PF-08634404 Plus Chemo vs. Chemo/Bev in 1L mCRC (C6461003)

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
[C6461003] An Interventional, Phase 3, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of PF-08634404 in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Treatment-Naïve Participants with Metastatic Colorectal Cancer
Principal Investigator
Headshot of Aman Opneja
Assistant Professor of Medicine
Protocol Number
IRB: PRO00119226
NCT: NCT07222800
Phase
Phase III
ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL